Kyoto University team develops pain reliever comparable to morphine

39 nogajun 6 8/5/2025, 3:47:18 AM japantimes.co.jp ↗

Comments (6)

burnt-resistor · 1h ago
A new class of selective α2B-adrenoceptor antagonist.
erickhill · 38m ago
Why is this written in such a way to only target cancer patients?
bitwize · 36m ago
The class of patients most likely to require opioids over long periods of time?
delusional · 33m ago
And a class disproportionately insensitive to long term negative side effects.
kelseyfrog · 49m ago
How is it different from Imiloxan?
petesergeant · 1h ago
Marginally more info, along with the title of the paper, but the doi is broken: https://medicalxpress.com/news/2025-08-discovery-analgesic-p...

There's also the alternative Journavx: https://en.wikipedia.org/wiki/Suzetrigine